edetic acid has been researched along with Local Neoplasm Recurrence in 79 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (3.80) | 18.2507 |
2000's | 3 (3.80) | 29.6817 |
2010's | 45 (56.96) | 24.3611 |
2020's | 28 (35.44) | 2.80 |
Authors | Studies |
---|---|
Afshar-Oromieh, A; Alberts, I; Bohn, KP; Mingels, C; Rominger, A | 1 |
Afshar-Oromieh, A; Alberts, I; Lanz, S; Mingels, C; Rominger, A; Schöder, H; Zacho, HD; Zwahlen, M | 1 |
Barret, E; Beauval, JB; Benziane Ouaritini, N; Brureau, L; Créhange, G; Dariane, C; Fiard, G; Fromont, G; Gauthé, M; Mathieu, R; Ploussard, G; Renard-Penna, R; Roubaud, G; Rouprêt, M; Ruffion, A; Sargos, P | 1 |
Bellò, M; Ceci, F; Chiofalo, V; Dall'Armellina, S; Deandreis, D; Gontero, P; Grimaldi, S; Guarneri, A; Iorio, GC; Liberini, V; Oderda, M; Passera, R; Ricardi, U; Rovera, G | 1 |
Demir, H; Hekimsoy, T; Isgoren, S; Koroglu, E | 1 |
Bartholomä, M; Derks, YHW; Ezziddin, S; Franssen, GM; Khreish, F; Maus, S; Nagarajah, J; Privé, BM; Rosar, F | 1 |
Janse Van Rensburg, C; Lawal, I; Lengana, T; Maes, A; Mazibuko, S; Mokoala, K; Moshokoa, E; Sathekge, MM; Van de Wiele, C; Vorster, M | 1 |
Cantarel, C; Cazeau, AL; Crombé, A; Letang, A; Merlin, C; Rousseau, C; Sargos, P | 1 |
Kisiel, N; Thomas, P | 1 |
Afshar-Oromieh, A; Alberts, I; Bütikofer, L; Rominger, A | 1 |
Omur, O; Tamer, F | 1 |
Metwalli, ZA; Tewari, SO; Xu, G | 1 |
Afshar-Oromieh, A; Alberts, I; Boxler, S; Gourni, E; Gross, T; Rahbar, K; Rominger, A; Sachpekidis, C; Thalmann, G | 1 |
Arafkas, M; Bania, J; Khosrawipour, T; Khosrawipour, V; Kulas, J; Migdal, P; Pigazzi, A; Schubert, J | 1 |
di Santo, G; Kroiss, AS; Nilica, B; Uprimny, C; Virgolini, IJ | 1 |
Evangelista, L; Sepulcri, M | 1 |
Aigner, RM; Kvaternik, H; Pernthaler, B | 1 |
Bartkowiak, D; Beer, AJ; Beer, M; Bolenz, C; Bottke, D; Krohn, T; Miksch, J; Prasad, V; Solbach, C; Thamm, R; Wiegel, T | 1 |
Buchholz, HG; Hoffmann, MA; Müller-Hübenthal, J; Richardsen, I; Schreckenberger, M; Trampert, L; Wieler, HJ | 1 |
Aasbrenn, M; Abd El-Aty, AM; Abdu, A; Abraha, HB; Achour, A; Acquaroni, M; Addeo, P; Agback, P; Agback, T; Al-Alwan, M; Al-Mazrou, A; Al-Mohanna, F; Aliste, M; Almquist, J; Andel, J; Ando, M; Angelov, A; Annuar, MSM; Antwi, K; Arroliga, AC; Arruda, SLM; Asch, SM; Averous, G; Ayaz, S; Ayer, GB; Bachellier, P; Ball, S; Banijamali, AR; Barden, TC; Bartoncini, S; Bedanie, G; Bellò, M; Benić, F; Berhe, GG; Bertiger, G; Beumer, JH; Bhandari, B; Bond, DS; Boules, M; Braüner Christensen, J; Brown-Johnson, C; Burgstaller, S; Cao, L; Capasso, C; Carlevato, R; Carvalho, AE; Ceci, F; Chagas, ATA; Chavan, SG; Chen, AP; Chen, HC; Chen, J; Chen, Q; Chen, Y; Chen, YF; Christ, ER; Chu, CW; Covey, JM; Coyne, GO'; Cristea, MC; Currie, MG; Dahdal, DN; Dai, L; Dang, Z; de Abreu, NL; de Carvalho, KMB; de la Plaza Llamas, R; Deandreis, D; Del Prete, S; Dennis, JA; Deur, J; Díaz Candelas, DA; Divyapriya, G; Djanani, A; Dodig, D; Doki, Y; Doroshow, JH; Dos Santos, RC; Durairaj, N; Dutra, ES; Eguchi, H; Eisterer, W; Ekmann, A; Elakkad, A; Evans, WE; Fan, W; Fang, Z; Faria, HP; Farris, SG; Fenoll, J; Fernandez-Botran, R; Flores, P; Fujita, J; Gan, L; Gandara, DR; Gao, X; Garcia, AA; Garrido, I; Gebru, HA; Gerger, A; Germano, P; Ghamande, S; Ghebeh, H; Giver Jensen, T; Go, A; Goichot, B; Goldwater, M; Gontero, P; Greil, R; Gruenberger, B; Guarneri, A; Guo, Y; Gupta, S; Haxholdt Lunn, T; Hayek, AJ; He, ML; Hellín, P; Hepprich, M; Hernández de Rodas, E; Hill, A; Hndeya, AG; Holdsworth, LM; Hookey, L; Howie, W; Hu, G; Huang, JD; Huang, SY; Hubmann, E; Hwang, SY; Imamura, H; Imperiale, A; Jiang, JQ; Jimenez, JL; Jin, F; Jin, H; Johnson, KL; Joseph, A; Juwara, L; Kalapothakis, E; Karami, H; Karayağiz Muslu, G; Kawabata, R; Kerwin, J; Khan, I; Khin, S; Kidanemariam, HG; Kinders, RJ; Klepov, VV; Koehler, S; Korger, M; Kovačić, S; Koyappayil, A; Kroll, MH; Kuban, J; Kummar, S; Kung, HF; Kurokawa, Y; Laengle, F; Lan, J; Leal, HG; Lee, MH; Lemos, KGE; Li, B; Li, G; Li, H; Li, X; Li, Y; Li, Z; Liebl, W; Lillaz, B; Lin, F; Lin, L; Lin, MCM; Lin, Y; Lin, YP; Lipton, RB; Liu, J; Liu, W; Liu, Z; Lu, J; Lu, LY; Lu, YJ; Ludwig, S; Luo, Y; Ma, L; Ma, W; Machado-Coelho, GLL; Mahmoodi, B; Mahoney, M; Mahvash, A; Mansour, FA; Mao, X; Marinho, CC; Masferrer, JL; Matana Kaštelan, Z; Melendez-Araújo, MS; Méndez-Chacón, E; Miletić, D; Miller, B; Miller, E; Miller, SB; Mo, L; Moazzen, M; Mohammadniaei, M; Montaz-Rosset, MS; Mousavi Khaneghah, A; Mühlethaler, K; Mukhopadhyay, S; Mulugeta, A; Nambi, IM; Navarro, S; Nazmara, S; Neumann, HJ; Newman, EM; Nguyen, HTT; Nicolato, AJPG; Nicolotti, DG; Nieva, JJ; Nilvebrant, J; Nocentini, A; Nugent, K; Nunez-Rodriguez, DL; Nygren, PÅ; Oberli, A; Oderda, M; Odisio, B; Oehler, L; Otludil, B; Overman, M; Özdemir, M; Pace, KA; Palm, H; Parchment, RE; Parise, R; Passera, R; Pavlovic, J; Pecherstorfer, M; Peng, Z; Pérez Coll, C; Petzer, A; Philipp-Abbrederis, K; Pichler, P; Piekarz, RL; Pilati, E; Pimentel, JDSM; Posch, F; Prager, G; Pressel, E; Profy, AT; Qi, P; Qi, Y; Qiu, C; Rajasekhar, B; Ramia, JM; Raynor, HA; Reis, VW; Reubi, JC; Ricardi, U; Riedl, JM; Romano, F; Rong, X; Rubinstein, L; Rumboldt, Z; Sabir, S; Safaeinili, N; Sala, BM; Sandoval Castillo, L; Sau, M; Sbhatu, DB; Schulte, T; Scott, V; Shan, H; Shao, Y; Shariatifar, N; Shaw, JG; She, Y; Shen, B; Shernyukov, A; Sheth, RA; Shi, B; Shi, R; Shum, KT; Silva, JC; Singh, A; Sinha, N; Sirajudeen, AAO; Slaven, J; Sliwa, T; Somme, F; Song, S; Steinberg, SM; Subramaniam, R; Suetta, C; Sui, Y; Sun, B; Sun, C; Sun, H; Sun, Y; Supuran, CT; Surger, M; Svartz, G; Takahashi, T; Takeno, A; Tam, AL; Tang, Z; Tanner, JA; Tannich, E; Taye, MG; Tekle, HT; Thomas, GJ; Tian, Y; Tobin, JV; Todd Milne, G; Tong, X; Une, C; Vela, N; Venkateshwaran, U; Villagrán de Tercero, CI; Wakefield, JD; Wampfler, R; Wan, M; Wang, C; Wang, J; Wang, L; Wang, S; Waser, B; Watt, RM; Wei, B; Wei, L; Weldemichael, MY; Wellmann, IA; Wen, A; Wild, D; Wilthoner, K; Winder, T; Wing, RR; Winget, M; Wöll, E; Wong, KL; Wong, KT; Wu, D; Wu, Q; Wu, Y; Xiang, T; Xiang, Z; Xu, F; Xu, L; Yamasaki, M; Yamashita, K; Yan, H; Yan, Y; Yang, C; Yang, H; Yang, J; Yang, N; Yang, Y; Yau, P; Yu, M; Yuan, Q; Zhan, S; Zhang, B; Zhang, H; Zhang, J; Zhang, N; Zhang, Y; Zhao, X; Zheng, BJ; Zheng, H; Zheng, W; Zhou, H; Zhou, X; Zhu, S; Zimmer, DP; Zionts, D; Zitella, A; Zlott, J; Zolfaghari, K; Zuo, D; Zur Loye, HC; Žuža, I | 1 |
Camacho, M; Carvalheira, JB; Costa, F; Etchebehere, E; Ferreira, U; Lima, M; Matheus, W; Mattiolli, A; Santos, A; Silva, C | 1 |
Calais, J; Carroll, PR; Czernin, J; Eiber, M; Fendler, WP; Feng, FY; Herrmann, K; Hope, TA; Kishan, AU; Kurhanewicz, J; Lawhn-Heath, C; Nickols, NG; Reiter, RE; Rettig, MB; Santos, RD; Simko, JP; Slavik, R | 1 |
Das, JP; Schöder, H; Wibmer, AG | 1 |
Arunraj, ST; Kumar, A; Kumar, R; Sakthivel, P; Singh, CA | 1 |
Arunraj, ST; Bhalla, AS; Kumar, R; Sakthivel, P; Thakar, A; Verma, H | 1 |
Afshar-Oromieh, A; Alberts, I; Bohn, KP; Fech, V; Hünermund, JN; Mingels, C; Rominger, A; Sachpekidis, C | 1 |
Cruel, T; Derolland, P; Giraudet, AL; Kryza, D; Moreau, A | 1 |
Dimitrakopoulou-Strauss, A; Haberkorn, U; Kopka, K; Pan, L; Sachpekidis, C; Strauss, DS | 1 |
Afshar-Oromieh, A; Alberts, I; Bohn, KP; Mingels, C; Prenosil, G; Rominger, A; Sari, H; Viscione, M | 1 |
Kunikowska, J; Pełka, K | 1 |
Hadaschik, B; Herrmann, K | 1 |
Fitzpatrick, C; Lynch, O; Marignol, L | 1 |
Eiber, M; Knorr, K; Maurer, T; Scheidhauer, K; Wester, HJ | 1 |
Taneja, SS | 1 |
Gorin, MA; Pomper, MG; Rowe, SP | 1 |
Eiber, M; Gschwend, JE; Horn, T; Maurer, T; Rauscher, I | 1 |
Stone, L | 1 |
Ahmadzadehfar, H; Bögemann, M; Rahbar, K; Schäfers, M; Stegger, L; Weckesser, M | 1 |
Denes, B; Gardiner, P | 1 |
Arora, S; Bal, C; Damle, NA; Dattagupta, S; Nalli, H; Parida, GK; Singhal, A | 1 |
Calais, J; Ceci, F; Eiber, M; Fendler, WP; Herrmann, K | 1 |
Bartenstein, P; Belka, C; Buchner, A; Eze, C; Fendler, WP; Ganswindt, U; Herlemann, A; Ilhan, H; Li, M; Rogowski, P; Schmidt-Hegemann, NS; Stief, C | 1 |
Basilico, GL; Biraghi, T; Briganti, A; Castellucci, P; Ceci, F; Cervati, V; Fanti, S; Farolfi, A; Graziani, T; Lambertini, A | 1 |
Bianchi, G; Coelho, RF; Davis, JW; Eissa, A; Elsherbiny, A; Micali, S; Patel, VR; Porpiglia, F; Prandini, N; Puliatti, S; Rassweiler, J; Rocco, B; Sighinolfi, MC | 1 |
Aiello, D; Alongi, F; Alongi, P; Cavalleri, S; De Bari, B; Fersino, S; Gregucci, F; Mazzola, R; Nicodemo, M; Salgarello, M | 1 |
Beer, AJ; Böhmer, D; Kotzerke, J; Maurer, T; Schlomm, T; Schmidberger, H | 1 |
Dettmann, K; Haberkorn, U; Jensen, JB; Langkilde, NC; Nielsen, JB; Petersen, LJ; Zacho, HD | 1 |
Afaq, A; Bomanji, J | 1 |
Knoll, P; Mirzaei, S; Zandieh, S | 1 |
Barbaud, M; Baumgartner, P; Campion, L; Colombié, M; Ferrer, L; Fleury, V; Frindel, M; Kraeber-Bodéré, F; Le Thiec, M; Maucherat, B; Rauscher, A; Rousseau, C; Rusu, D; Thierry-Morel, A | 1 |
Cusick, T; Emmett, L; Ende, D; Hickey, A; Ho, B; Kooner, R; Nandurkar, R; O'Neill, G; Stricker, P; van Leeuwen, P; Woo, H; Yuen, C | 1 |
Campbell, A; Francis, R; McCarthy, M; Tang, C; Watts, J | 1 |
Burger, IA; Calais, J; Carroll, PR; Czernin, J; Eiber, M; Emmett, L; Fendler, WP; Feng, FY; Flavell, RR; Gartmann, J; Herrmann, K; Hope, TA; Ilhan, H; Mishoe, A; Nguyen, HG; Okamoto, S; Reiter, RE; Rettig, MB; Rischpler, C; Schoder, H; Slavik, R; Small, EJ; Smith, R; Wetter, A; Zacho, HD | 1 |
Boreta, L; Carroll, PR; Feng, FY; Gadzinski, AJ; Greene, K; Hope, TA; Nguyen, HG; Quanstrom, K; Wu, SY; Xu, M | 1 |
Bradley, CA | 1 |
Baroni, RH; Carneiro, A; Cunha, ML; Garcia, RG; Mariotti, GC; Smaletz, O | 1 |
Hadaschik, B; Ost, P | 1 |
Bach-Gansmo, T; Calais, J; Ceci, F; Czernin, J; Dahlbom, M; Eiber, M; Elashoff, D; Fendler, WP; Gartmann, J; Grogan, T; Hofman, MS; Hope, TA; Jadvar, H; Kishan, AU; Lok, V; Nanni, C; Nguyen, K; Reiter, RE; Rettig, MB; Rischpler, C; Savir-Baruch, B; Slavik, R | 1 |
Afshar-Oromieh, A; Fenchel, M; Hadaschik, BA; Kuru, TH; Roethke, MC; Schlemmer, HP | 1 |
Afshar-Oromieh, A; Avtzi, E; Boxler, S; Debus, J; Eder, M; Eisenhut, M; Giesel, FL; Haberkorn, U; Hadaschik, BA; Holland-Letz, T; Kopka, K; Kratochwil, C; Linhart, HG; Weichert, W | 1 |
Eilles, C; Hellwig, D; Moosbauer, J | 1 |
Bektic, J; Castellucci, P; Ceci, F; Decristoforo, C; Fanti, S; Geraldo, L; Horninger, W; Kendler, D; Kroiss, A; Lukas, P; Nilica, B; Uprimny, C; Virgolini, IJ | 1 |
Behrendt, FF; Drude, NI; Heidenreich, A; Mottaghy, FM; Pfister, D; Verburg, FA; Vogg, A; Vöö, S | 1 |
Bouter, C; Hijazi, S; Lotz, J; Meller, B; Meller, J; Ritter, CO; Sahlmann, CO; Ströbel, P; Trojan, L | 1 |
Chin, FT; Gambhir, SS; Hancock, S; Iagaru, A; Jamali, M; Loening, A; Minamimoto, R; Schneider, B; Vasanawala, S | 1 |
Bengel, FM; Christiansen, H; Derlin, T; Henkenberens, C; Merseburger, AS; Ross, TL; Vogel-Claussen, J; von Klot, CA; Wester, HJ | 1 |
Beer, AJ; Eiber, M; Gschwend, JE; Maurer, T; Rauscher, I; Schottelius, M; Schwaiger, M; Souvatzoglou, M; Vag, T; Weirich, G; Wester, HJ; Wirtz, M | 1 |
Becker, A; Blümel, C; Düwel, C; Eiber, M; Gschwend, JE; Maurer, T; Wagner-Thiessen, E; Westenfelder, K | 1 |
Düwel, C; Eiber, M; Maurer, T | 1 |
Behrendt, FF; Knuechel, R; Mottaghy, FM; Pfister, D; Steib, F; Verburg, FA | 1 |
Blex, S; Bockisch, A; Forsting, M; Gomez, B; Jentzen, W; Lütje, S; Poeppel, TD; Schaarschmidt, BM; Umutlu, L; Wetter, A | 1 |
Anees K, M; Jayaprakash, PG; Joy, A; Madhavan, J; Nair, S; Nanabala, R; Pillai, MR; Sasikumar, A | 1 |
Dettmann, K; Haberkorn, U; Nielsen, JB; Petersen, LJ; Zacho, HD | 1 |
Eade, T; Emmett, L; Guo, L; Ho, B; Hruby, G; Hsiao, E; Hunter, J; Kneebone, A; Kwong, C; Schembri, G | 1 |
Czepczyński, R; Gryczyńska, M; Kosowicz, J; Mikołajczak, R; Sowiński, J; Ziemnicka, K | 1 |
Diamandis, EP; Yu, H | 1 |
Bardiès, M; Chatal, JF; Chetanneau, A; Faivre-Chauvet, A; Gestin, JF; Mease, RC; Meinken, GE; Sai-Maurel, C; Srivastava, SC | 1 |
Black, KL; Cloughesy, T; Farahani, K; Gobin, YP; Grous, J; Hoh, CK; Huang, SC; Nelson, G; Phelps, M; Zhou, Y | 1 |
Cerio, R; Cook, LJ; Kersey, P; Marks, R; Punjabi, S | 1 |
9 review(s) available for edetic acid and Local Neoplasm Recurrence
Article | Year |
---|---|
The Diagnostic Performance of 18F-PSMA-1007 PET/CT in Prostate Cancer Patients with Early Recurrence after Definitive Therapy with a PSA <10 ng/ml.
Topics: Aged; Aged, 80 and over; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Niacinamide; Oligopeptides; Positron Emission Tomography Computed Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals | 2022 |
Topics: Antigens, Surface; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Glutamate Carboxypeptidase II; Humans; Male; Neoplasm Recurrence, Local; Oligopeptides; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms | 2017 |
[PET-CT and PET-MRI of the prostate : From
Topics: Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Oligopeptides; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2017 |
Novel technology of molecular radio-guidance for lymph node dissection in recurrent prostate cancer by PSMA-ligands.
Topics: Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Lymph Node Excision; Lymph Nodes; Male; Neoplasm Recurrence, Local; Oligopeptides; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Surgery, Computer-Assisted | 2018 |
The role of 68Ga-PSMA PET/CT scan in biochemical recurrence after primary treatment for prostate cancer: a systematic review of the literature.
Topics: Antigens, Surface; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Glutamate Carboxypeptidase II; Humans; Male; Neoplasm Recurrence, Local; Oligopeptides; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals | 2018 |
Prostate-specific membrane antigen positron emission tomography in the management of recurrent prostate cancer.
Topics: Edetic Acid; Evidence-Based Medicine; Gallium Isotopes; Gallium Radioisotopes; Humans; Image Interpretation, Computer-Assisted; Male; Neoplasm Recurrence, Local; Oligopeptides; Positron Emission Tomography Computed Tomography; Prostate; Prostatic Neoplasms; Reproducibility of Results; Sensitivity and Specificity | 2018 |
[The role of molecular imaging (PET-CT) in the diagnostic and treatment pf prostate cancer].
Topics: Edetic Acid; Gallium Radioisotopes; Humans; Magnetic Resonance Imaging; Male; Molecular Imaging; Multimodal Imaging; Neoplasm Recurrence, Local; Oligopeptides; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals | 2019 |
[Ga-68-PSMA PET/CT for prostate cancer].
Topics: Antigens, Surface; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Glutamate Carboxypeptidase II; Humans; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Oligopeptides; Positron-Emission Tomography; Prostate; Prostatic Neoplasms; Radiographic Image Enhancement; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
[Will 68Ga-PSMA PET become the New Imaging Standard for Prostate Cancer?].
Topics: Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Oligopeptides; Positron-Emission Tomography; Prognosis; Prostate; Prostatic Neoplasms | 2016 |
12 trial(s) available for edetic acid and Local Neoplasm Recurrence
Article | Year |
---|---|
A randomised, prospective and head-to-head comparison of [68Ga]Ga-PSMA-11 and [18F]PSMA-1007 for the detection of recurrent prostate cancer in PSMA-ligand PET/CT-Protocol design and rationale.
Topics: Edetic Acid; Gallium Radioisotopes; Humans; Ligands; Male; Neoplasm Recurrence, Local; Niacinamide; Oligopeptides; Positron Emission Tomography Computed Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Randomized Controlled Trials as Topic | 2022 |
Topics: 3-Hydroxybutyric Acid; Acetazolamide; Acrylates; Administration, Intravenous; Adolescent; Adult; Aerosols; Afghanistan; Aflatoxin M1; Agaricales; Aged; Aged, 80 and over; Agricultural Irrigation; Air Pollutants; alpha-L-Fucosidase; Amino Acid Sequence; Androgen Antagonists; Animals; Antibodies, Bacterial; Antigens, Bacterial; Antineoplastic Agents; Antioxidants; Apoptosis; Artifacts; Autophagy; B7-H1 Antigen; Bacterial Proteins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Bile; Bioelectric Energy Sources; Biosensing Techniques; Body Mass Index; Brain; Brazil; Breast Neoplasms; Bufo arenarum; Burkholderia; C-Reactive Protein; Cadmium; Carbon Compounds, Inorganic; Carbon-13 Magnetic Resonance Spectroscopy; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Carcinoma, Transitional Cell; Case-Control Studies; CD4-Positive T-Lymphocytes; Cell Count; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Characiformes; Child; China; Cities; Cobalt; Colonic Neoplasms; Copper Sulfate; Cross-Sectional Studies; Cyclin-Dependent Kinase Inhibitor p16; Cytokines; Deoxycytidine; Diagnosis, Differential; Digestive System; Dihydroxyphenylalanine; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; DNA Barcoding, Taxonomic; DNA, Bacterial; Dose-Response Relationship, Drug; Down-Regulation; Edetic Acid; Electrochemical Techniques; Electrodes; Embolization, Therapeutic; Embryo, Nonmammalian; Environmental Monitoring; Enzyme-Linked Immunosorbent Assay; Epithelial-Mesenchymal Transition; Fatty Acids; Feces; Female; Follow-Up Studies; Food Contamination; Forkhead Box Protein M1; Fresh Water; Fungicides, Industrial; Gallium Isotopes; Gallium Radioisotopes; Gastrectomy; Gastric Bypass; Gastric Outlet Obstruction; Gastroplasty; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, Bacterial; Genetic Markers; Genome, Bacterial; Genome, Mitochondrial; Glioma; Glycogen Synthase Kinase 3 beta; Goats; Gonads; Guatemala; Halomonadaceae; HEK293 Cells; Helicobacter Infections; Helicobacter pylori; Hepacivirus; Histone-Lysine N-Methyltransferase; Hormones; Humans; Hydroxybutyrate Dehydrogenase; Hypersplenism; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Iran; Japan; Lactuca; Laparoscopy; Larva; Ligands; Liver Neoplasms; Lymphocyte Activation; Macrophages; Malaria; Male; Mercury; Metabolic Syndrome; Metals, Heavy; Mice; Middle Aged; Milk, Human; Mitochondria; Models, Molecular; Molecular Structure; Mothers; Multilocus Sequence Typing; Muscles; Mutation; Nanocomposites; Nanotubes, Carbon; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Cells, Circulating; Neoplastic Stem Cells; Neuroimaging; Nitriles; Nitrogen Isotopes; Non-alcoholic Fatty Liver Disease; Nuclear Magnetic Resonance, Biomolecular; Obesity; Obesity, Morbid; Oligopeptides; Oxidation-Reduction; Pancreatic Neoplasms; Particle Size; Particulate Matter; Pepsinogen A; Pesticides; Pharmacogenetics; Phosphatidylinositol 3-Kinases; Phospholipids; Phylogeny; Plasmodium ovale; Plasmodium vivax; Platelet Count; Polyhydroxyalkanoates; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postoperative Complications; Pregnancy; Prevalence; Prognosis; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Protein Domains; Proto-Oncogene Proteins c-akt; Proton Magnetic Resonance Spectroscopy; Pseudogenes; PTEN Phosphohydrolase; Pyrazoles; Pyrimidines; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Rats, Long-Evans; Rats, Sprague-Dawley; RAW 264.7 Cells; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptor, Notch3; Receptors, G-Protein-Coupled; Receptors, Urokinase Plasminogen Activator; Recombinant Proteins; Repressor Proteins; Resveratrol; Retrospective Studies; Risk Assessment; Risk Factors; RNA, Messenger; RNA, Ribosomal, 16S; Salinity; Salvage Therapy; Seasons; Sequence Analysis, DNA; Seroepidemiologic Studies; Signal Transduction; Skin; Snails; Soluble Guanylyl Cyclase; Solutions; Spain; Species Specificity; Spheroids, Cellular; Splenic Artery; Stomach Neoplasms; Streptococcus pneumoniae; Structure-Activity Relationship; Sulfonamides; Sunlight; Surface Properties; Surgical Instruments; Surgical Wound Infection; Survival Rate; Tetrahydrouridine; Thinness; Thrombocytopenia; Tissue Distribution; Titanium; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Tumor Microenvironment; Tumor Necrosis Factor-alpha; Turkey; Ubiquinone; Urologic Neoplasms; Viral Envelope Proteins; Wastewater; Water Pollutants, Chemical; Weather; Wnt Signaling Pathway; Xenograft Model Antitumor Assays; Young Adult | 2007 |
Topics: Aged; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Oligopeptides; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prostate; Prostatectomy; Prostatic Neoplasms; Retrospective Studies | 2019 |
A Multicenter Prospective Clinical Trial of
Topics: Aged; Aged, 80 and over; Antigens, Surface; Bone and Bones; Carcinoma; Cross-Sectional Studies; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Glutamate Carboxypeptidase II; Humans; Kallikreins; Male; Middle Aged; Neoplasm Recurrence, Local; Oligopeptides; Pelvis; Positron Emission Tomography Computed Tomography; Prospective Studies; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms | 2019 |
Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial.
Topics: Adult; Aged; Aged, 80 and over; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Oligopeptides; Positron-Emission Tomography; Predictive Value of Tests; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals | 2019 |
Location of Recurrence by Gallium-68 PSMA-11 PET Scan in Prostate Cancer Patients Eligible for Salvage Radiotherapy.
Topics: Aged; Edetic Acid; Female; Follow-Up Studies; Gallium Isotopes; Gallium Radioisotopes; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Oligopeptides; Positron-Emission Tomography; Prostatectomy; Prostatic Neoplasms; Radiotherapy, Adjuvant; Reproducibility of Results; Retrospective Studies; Salvage Therapy | 2019 |
Topics: Aged; Carboxylic Acids; Contrast Media; Cyclobutanes; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Oligopeptides; Positron Emission Tomography Computed Tomography; Prospective Studies; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms | 2019 |
Pilot Comparison of ⁶⁸Ga-RM2 PET and ⁶⁸Ga-PSMA-11 PET in Patients with Biochemically Recurrent Prostate Cancer.
Topics: Aged; Aged, 80 and over; Cohort Studies; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Image Processing, Computer-Assisted; Intestine, Small; Lymph Nodes; Male; Neoplasm Recurrence, Local; Oligopeptides; Organometallic Compounds; Pilot Projects; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Salivary Glands; Seminal Vesicles; Tissue Distribution; Whole Body Imaging | 2016 |
(68)Ga-PSMA ligand PET/CT-based radiotherapy in locally recurrent and recurrent oligometastatic prostate cancer : Early efficacy after primary therapy.
Topics: Aged; Aged, 80 and over; Biomarkers, Tumor; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Oligopeptides; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Radiotherapy, Adjuvant; Radiotherapy, Image-Guided; Treatment Outcome | 2016 |
Two peptide receptor ligands (99m)Tc-EDDA/HYNIC-Tyr(3)-octreotide and (99m)Tc-EDDA/HYNIC-(D)Glu-octagastrin for scintigraphy of medullary thyroid carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Animals; Carcinoma, Medullary; Edetic Acid; Female; Gastrins; Humans; Hydrazines; Indium Radioisotopes; Male; Mice; Mice, Inbred BALB C; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Nicotinic Acids; Organotechnetium Compounds; Radionuclide Imaging; Sensitivity and Specificity; Thyroid Gland; Thyroid Neoplasms | 2007 |
Intracarotid infusion of RMP-7, a bradykinin analog, and transport of gallium-68 ethylenediamine tetraacetic acid into human gliomas.
Topics: Adult; Aged; Antineoplastic Agents; Biological Transport; Bradykinin; Brain Neoplasms; Carboplatin; Drug Therapy, Combination; Edetic Acid; Female; Gallium Radioisotopes; Glioma; Humans; Injections, Intra-Arterial; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Tomography, Emission-Computed | 1997 |
Solasodine glycoalkaloids: a novel topical therapy for basal cell carcinoma. A double-blind, randomized, placebo-controlled, parallel group, multicenter study.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Basal Cell; Double-Blind Method; Female; Glycosides; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Occlusive Dressings; Patient Dropouts; Pharmaceutical Vehicles; Skin Neoplasms; Solanaceous Alkaloids; Treatment Failure; Treatment Outcome | 2008 |
58 other study(ies) available for edetic acid and Local Neoplasm Recurrence
Article | Year |
---|---|
PSMA-Ligand Uptake in Disseminated Epidermoid Cysts in a PSMA PET/CT of a Patient With Recurrent Prostate Cancer.
Topics: Aged; Edetic Acid; Epidermal Cyst; Humans; Ligands; Male; Neoplasm Recurrence, Local; Oligopeptides; Positron Emission Tomography Computed Tomography; Prostatectomy; Prostatic Neoplasms; Retrospective Studies | 2021 |
Comparing the clinical performance and cost efficacy of [
Topics: Decision Support Techniques; Edetic Acid; Fluorine Radioisotopes; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Markov Chains; Neoplasm Recurrence, Local; Niacinamide; Oligopeptides; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Retrospective Studies | 2022 |
Restaging of Patients with Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy Using [
Topics: Disease Management; Edetic Acid; Gallium Radioisotopes; Humans; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Retrospective Studies | 2022 |
Event-free survival after
Topics: Edetic Acid; Gallium Radioisotopes; Humans; Male; Neoplasm Recurrence, Local; Oligopeptides; Positron Emission Tomography Computed Tomography; Progression-Free Survival; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Salvage Therapy; Tomography, X-Ray Computed | 2022 |
PET/CT With 68Ga-PSMA and 18F-FDG in Metastatic Adenoid Cystic Carcinoma: Report of 2 Cases.
Topics: Carcinoma, Adenoid Cystic; Edetic Acid; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms | 2022 |
89Zr-PSMA-617 PET/CT May Reveal Local Recurrence of Prostate Cancer Unidentified by 68Ga-PSMA-11 PET/CT.
Topics: Aged; Dipeptides; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Humans; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Zirconium | 2022 |
Bone Uptake in Prostate Cancer Patients: Diagnostic Performances of PSMA-RADS v1.0, Clinical, Biological, and 68 Ga-PSMA-11 PET Features to Predict Metastasis After Biochemical Recurrence.
Topics: Aged; Bone Neoplasms; Data Systems; Edetic Acid; Gallium Radioisotopes; Humans; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Retrospective Studies | 2022 |
Potential Pitfall in the Interpretation of Ganglioneuronal Uptake of 18 F-PSMA-1007 PET/CT Scans Performed With a High Spatial Resolution Digital PET Scanner.
Topics: Aged; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Neoplasm Recurrence, Local; Niacinamide; Oligopeptides; Positron Emission Tomography Computed Tomography; Prostatectomy; Prostatic Neoplasms | 2022 |
Incidental Meningioma With Altered PSMA Expression After Systemic Hormone Therapy and Local Radiotherapy Detected by 68 Ga-PSMA PET/CT.
Topics: Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prostate-Specific Antigen; Prostatectomy | 2023 |
Pitfall of 18 F-PSMA PyL PET/CT Imaging of a Displaced Urinary Bladder as Recurrent Prostate Malignancy.
Topics: Carcinoma; Edetic Acid; Gallium Radioisotopes; Humans; Male; Neoplasm Recurrence, Local; Pelvis; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Urinary Bladder | 2023 |
Dynamic patterns of [
Topics: Edetic Acid; Gallium Radioisotopes; Humans; Male; Neoplasm Recurrence, Local; Oligopeptides; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Retrospective Studies | 2020 |
Evaluation of Cell-detaching Effect of EDTA in Combination with Oxaliplatin for a Possible Application in HIPEC After Cytoreductive Surgery: A Preliminary in-vitro Study.
Topics: Antineoplastic Agents; Combined Modality Therapy; Cytoreduction Surgical Procedures; Edetic Acid; HT29 Cells; Humans; Hyperthermia, Induced; Neoplasm Recurrence, Local; Neoplasm, Residual; Oxaliplatin; Peritoneal Neoplasms | 2019 |
Visualization of malignant infiltration of the thoracic duct on
Topics: Edetic Acid; Gallium Radioisotopes; Humans; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Thoracic Duct | 2020 |
Re: A Prospective Head-to-Head Comparison of 18F-Fluciclovine With 68Ga-PSMA-11 in Biochemical Recurrence of Prostate Cancer in PET/CT.
Topics: Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Membrane Glycoproteins; Neoplasm Recurrence, Local; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Prospective Studies; Prostatic Neoplasms | 2020 |
A Prospective Head-to-Head Comparison of 18F-Fluciclovine With 68Ga-PSMA-11 in Biochemical Recurrence of Prostate Cancer in PET/CT: A Special Aspect in Imaging Local Recurrence: Reply.
Topics: Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Membrane Glycoproteins; Neoplasm Recurrence, Local; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Prospective Studies; Prostatic Neoplasms | 2020 |
Interobserver variability, detection rate, and lesion patterns of
Topics: Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Neoplasm Recurrence, Local; Observer Variation; Oligopeptides; Positron Emission Tomography Computed Tomography; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Recurrence | 2020 |
Diagnostic Performance of 68Ga-PSMA-11 Positron-emission-tomography/Computed-tomography in a Large Cohort of Patients with Biochemical Recurrence of Prostate Carcinoma.
Topics: Cohort Studies; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Gene Expression Regulation; Humans; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Oligopeptides; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Retrospective Studies; Risk Assessment; Treatment Outcome | 2020 |
PSMA whole-body tumor burden in primary staging and biochemical recurrence of prostate cancer.
Topics: Edetic Acid; Humans; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Retrospective Studies; Tumor Burden | 2021 |
False positive PSMA PET for tumor remnants in the irradiated prostate and other interpretation pitfalls in a prospective multi-center trial.
Topics: Edetic Acid; Humans; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prospective Studies; Prostate; Prostatectomy; Prostatic Neoplasms | 2021 |
Urachal remnant metastasis detected on [
Topics: Edetic Acid; Gallium Radioisotopes; Humans; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Recurrence; Retrospective Studies | 2021 |
68Ga-PSMA PET/CT Scan on Postoperative Assessment of Sinonasal Glomangiopericytoma.
Topics: Edetic Acid; Endothelial Cells; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Neoplasm Recurrence, Local; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms | 2021 |
Pterygoid Base Pneumatization Simulating Residual Disease-A Pitfall of Structural Imaging in Juvenile Nasal Angiofibroma.
Topics: Angiofibroma; Edetic Acid; Humans; Magnetic Resonance Imaging; Male; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms | 2021 |
The influence of digital PET/CT on diagnostic certainty and interrater reliability in [
Topics: Edetic Acid; Gallium Radioisotopes; Humans; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Reproducibility of Results; Retrospective Studies | 2021 |
Incidental Finding of Hibernoma in Prostate-Specific Membrane Antigen PET/CT.
Topics: Aged; Edetic Acid; Humans; Incidental Findings; Lipoma; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms | 2021 |
Pharmacokinetic studies of [
Topics: Edetic Acid; Humans; Kinetics; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Retrospective Studies | 2021 |
Feasibility of late acquisition [68Ga]Ga-PSMA-11 PET/CT using a long axial field-of-view PET/CT scanner for the diagnosis of recurrent prostate cancer-first clinical experiences.
Topics: Edetic Acid; Feasibility Studies; Humans; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Retrospective Studies | 2021 |
Myelofibrosis Pattern in 68Ga-PSMA PET/CT of a Patient With Recurrence Prostate Cancer.
Topics: Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Primary Myelofibrosis; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms | 2022 |
Re: Diagnostic Accuracy of Ga-68-HBED-CC-PSMA-ligand-PET/CT Before Salvage Lymph Node Dissection for Recurrent Prostate Cancer.
Topics: Edetic Acid; Humans; Lymph Node Excision; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms | 2017 |
Re: Impact of Ga-68 PSMA-11 PET on Management in Patients with Biochemically Recurrent Prostate Cancer.
Topics: Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Neoplasm Recurrence, Local; Oligopeptides; Prostatic Neoplasms | 2017 |
Molecular Imaging of Prostate Cancer: Choosing the Right Agent.
Topics: Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Molecular Imaging; Neoplasm Recurrence, Local; Oligopeptides; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms | 2018 |
Imaging: Predicting
Topics: Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Neoplasm Recurrence, Local; Nomograms; Oligopeptides; Positron Emission Tomography Computed Tomography; Prostatectomy; Prostatic Neoplasms | 2018 |
Advantage of
Topics: Edetic Acid; Fluorine Radioisotopes; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Neoplasm Recurrence, Local; Niacinamide; Oligopeptides; Organometallic Compounds; Positron-Emission Tomography; Prostatic Neoplasms | 2018 |
Comparison of
Topics: Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Neoplasm Recurrence, Local; Oligopeptides; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms | 2018 |
Recurrent Medullary Thyroid Carcinoma on 68Ga-Prostate-Specific Membrane Antigen PET/CT: Exploring New Theranostic Avenues.
Topics: Adult; Carcinoma, Neuroendocrine; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Neoplasm Recurrence, Local; Oligopeptides; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2018 |
Reply: Comparison of
Topics: Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Neoplasm Recurrence, Local; Oligopeptides; Positron Emission Tomography Computed Tomography; Prospective Studies; Prostatic Neoplasms | 2018 |
Outcome after PSMA PET/CT based radiotherapy in patients with biochemical persistence or recurrence after radical prostatectomy.
Topics: Aged; Aged, 80 and over; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Oligopeptides; Positron Emission Tomography Computed Tomography; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Radiotherapy Planning, Computer-Assisted; Salvage Therapy | 2018 |
Incidental Detection of Basaloid Thymic Carcinoma With
Topics: Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Incidental Findings; Male; Middle Aged; Neoplasm Recurrence, Local; Oligopeptides; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Thymoma; Thymus Neoplasms; Treatment Outcome | 2018 |
Could 68-Ga PSMA PET/CT become a new tool in the decision-making strategy of prostate cancer patients with biochemical recurrence of PSA after radical prostatectomy? A preliminary, monocentric series.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Decision Making; Edetic Acid; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Radiopharmaceuticals; Retrospective Studies; Salvage Therapy | 2018 |
[PSMA-PET/CT has to be performed in every patient with biochemical recurrence following radical prostatectomy for early tumor detection].
Topics: Antigens, Surface; Early Detection of Cancer; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Glutamate Carboxypeptidase II; Humans; Male; Neoplasm Recurrence, Local; Oligopeptides; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals | 2018 |
68Ga-PSMA PET/CT in Patients With Biochemical Recurrence of Prostate Cancer: A Prospective, 2-Center Study.
Topics: Antigens, Surface; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Glutamate Carboxypeptidase II; Humans; Male; Neoplasm Recurrence, Local; Oligopeptides; Positron Emission Tomography Computed Tomography; Prospective Studies; Prostatic Neoplasms; Radiopharmaceuticals; Retrospective Studies | 2018 |
68Ga-PSMA-11 PET-CT study in prostate cancer patients with biochemical recurrence and non-contributive 18F-Choline PET-CT: Impact on therapeutic decision-making and biomarker changes.
Topics: Aged; Aged, 80 and over; Choline; Decision Making; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Kallikreins; Male; Middle Aged; Neoplasm Recurrence, Local; Oligopeptides; Positron Emission Tomography Computed Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Retrospective Studies | 2019 |
Topics: Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Neoplasm Recurrence, Local; Oligopeptides; Prospective Studies; Prostatic Neoplasms | 2019 |
Paradoxical Early Increase in Prostate-Specific Membrane Antigen Uptake Following Cryoablation for Local Recurrence After Radical Prostatectomy.
Topics: Adult; Cryosurgery; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Neoplasm Recurrence, Local; Oligopeptides; Positron Emission Tomography Computed Tomography; Postoperative Complications; Prostatectomy; Prostatic Neoplasms; Radiopharmaceuticals | 2019 |
Re: Assessment of
Topics: Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Membrane Glycoproteins; Neoplasm Recurrence, Local; Organometallic Compounds; Positron-Emission Tomography; Prospective Studies; Prostatic Neoplasms | 2019 |
Hybrid positron emission tomography-magnetic resonance imaging with gallium 68 prostate-specific membrane antigen tracer: a next step for imaging of recurrent prostate cancer-preliminary results.
Topics: Aged; Antigens, Surface; Biomarkers, Tumor; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Glutamate Carboxypeptidase II; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Oligopeptides; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prostatic Neoplasms; Radiopharmaceuticals; Whole Body Imaging | 2013 |
The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer.
Topics: Aged; Aged, 80 and over; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Oligopeptides; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
(68)Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate?
Topics: Adult; Aged; Aged, 80 and over; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Oligopeptides; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Extent of disease in recurrent prostate cancer determined by [(68)Ga]PSMA-HBED-CC PET/CT in relation to PSA levels, PSA doubling time and Gleason score.
Topics: Adult; Aged; Antigens, Surface; Edetic Acid; Gallium Radioisotopes; Glutamate Carboxypeptidase II; Humans; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Retrospective Studies; Tomography, X-Ray Computed | 2016 |
Biphasic ⁶⁸Ga-PSMA-HBED-CC-PET/CT in patients with recurrent and high-risk prostate carcinoma.
Topics: Adult; Aged; Carcinoma; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Oligopeptides; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals | 2016 |
Intrapatient Comparison of 111In-PSMA I&T SPECT/CT and Hybrid 68Ga-HBED-CC PSMA PET in Patients With Early Recurrent Prostate Cancer.
Topics: Aged; Antigens, Surface; Edetic Acid; Gallium Radioisotopes; Glutamate Carboxypeptidase II; Humans; Indium Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Retrospective Studies; Single Photon Emission Computed Tomography Computed Tomography | 2016 |
[Rectal mucosa metastasis in recurrent prostate cancer : (68)Ga-PSMA-PET/CT allows targeted salvage radiotherapy].
Topics: Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Intestinal Mucosa; Male; Middle Aged; Neoplasm Recurrence, Local; Oligopeptides; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy, Image-Guided; Rectal Neoplasms; Salvage Therapy; Treatment Outcome | 2016 |
Strong [(68)Ga]PSMA-HBED-CC accumulation in non-cancerous prostate tissue surrounding a PSMA-negative prostate carcinoma recurrence.
Topics: Aged; Antigens, Surface; Edetic Acid; False Positive Reactions; Gallium Isotopes; Gallium Radioisotopes; Glutamate Carboxypeptidase II; Humans; Male; Margins of Excision; Neoplasm Recurrence, Local; Oligopeptides; Organometallic Compounds; Prostate; Prostatic Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Up-Regulation | 2016 |
Optimization of Acquisition time of 68Ga-PSMA-Ligand PET/MRI in Patients with Local and Metastatic Prostate Cancer.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Edetic Acid; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Time Factors | 2016 |
Diagnostic Value of 68Ga PSMA-11 PET/CT Imaging of Brain Tumors-Preliminary Analysis.
Topics: Adult; Aged; Brain Neoplasms; Child; Edetic Acid; Female; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Glioblastoma; Glioma; Humans; Lymphoma; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Neoplasm Recurrence, Local; Oligopeptides; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Whole Body Imaging; Young Adult | 2017 |
Incidental Detection of Thyroid Metastases From Renal Cell Carcinoma Using 68Ga-PSMA PET/CT to Assess Prostate Cancer Recurrence.
Topics: Aged; Carcinoma, Renal Cell; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Incidental Findings; Kidney Neoplasms; Male; Neoplasm Recurrence, Local; Oligopeptides; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Thyroid Neoplasms | 2017 |
Delineating biochemical failure with
Topics: Cohort Studies; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Neoplasm Recurrence, Local; Oligopeptides; Positron-Emission Tomography; Prostate; Prostatic Neoplasms; Treatment Failure | 2017 |
Ultrasensitive time-resolved immunofluorometric assay of prostate-specific antigen in serum and preliminary clinical studies.
Topics: Adolescent; Adult; Aged; Alkaline Phosphatase; Antibodies, Monoclonal; Chromatography, High Pressure Liquid; Edetic Acid; Female; Fluoroimmunoassay; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Quality Control; Reference Values; Sensitivity and Specificity; Terbium | 1993 |
Pre-clinical and clinical studies of two new bifunctional chelating agents for immunoscintigraphy with 111In-anti-CEA monoclonal antibody.
Topics: Adenocarcinoma; Animals; Antibodies, Bispecific; Antibodies, Monoclonal; Carcinoembryonic Antigen; Chelating Agents; Colorectal Neoplasms; Edetic Acid; Female; Guinea Pigs; Humans; Indium Radioisotopes; Male; Mice; Mice, Nude; Neoplasm Recurrence, Local; Pentetic Acid; Radioimmunodetection | 1996 |